Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
NYSE:HIPO

Hippo Q3 2026 Earnings Date & Estimates

Hippo logo
$39.11 +0.72 (+1.89%)
As of 10:58 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Hippo is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. The conference call is scheduled for 8:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
8:00 AM ET

What Analysts Expect from Hippo in Q3 2026

Hippo is expected to post earnings of $0.32 per share on revenue of $153.88 million. In the same quarter a year earlier Hippo reported $0.70 per share on revenue of $120.60 million. Hippo last reported on July 30, 2026, posting $0.79 per share and beating the -$0.17 consensus estimate. Hippo has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
$0.32
Expected Revenue
$153.88 million
Prior-Year EPS
$0.70
Prior-Year Revenue
$120.60 million
Expected EPS Growth
-54.3%
Expected Revenue Growth
+27.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.79 (Beat by +$0.96)
Last Quarter Revenue
$144.70 million
EPS Beat Rate
4 of last 8 quarters

Hippo Q3 2026 Earnings FAQ

Hippo (NYSE:HIPO) is estimated to report Q3 2026 earnings on Thursday, October 29, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Hippo's Q3 2026 earnings conference call is scheduled for Thursday, October 29, 2026 at 8:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Hippo to post earnings of $0.32 per share for Q3 2026.

The consensus revenue estimate for Hippo is $153.88 million for Q3 2026.

Hippo Earnings Headlines

Hyenas feast on hippo until a male lion interrupts
Microscopic footage reveals immune cells destroying cancer cells
Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden. One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency, has just cleared an important FDA milestone.tc pixel
See More Hippo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hippo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hippo and other key companies, straight to your email.

About Hippo

Hippo (NYSE:HIPO) is a technology-focused insurance company that provides home insurance and related services to homeowners in the United States. Operating under the Hippo brand, the company uses digital tools, data analytics and a streamlined online experience to help customers obtain coverage, manage policies and receive support.

Hippo’s offerings are designed to protect residential properties and personal belongings against covered risks, while also emphasizing proactive home protection. Its services may include digital home assessments, smart-home devices, maintenance resources and assistance intended to help customers identify and address potential problems before they result in an insurance claim. The company also works with insurance partners and subsidiaries to support policy administration and underwriting.

Hippo was founded in 2015 by Assaf Wand and Eyal Navon with the goal of modernizing the traditional homeowners insurance experience. The company became publicly traded on the New York Stock Exchange in 2021 following a business combination with Reinvent Technology Partners Z. Hippo serves customers across multiple U.S. states, with availability and coverage features varying by jurisdiction.

View Hippo Profile